![Christopher Twitty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Twitty
Technik-/Wissenschafts-/F&E-Leiter bei
SKYE BIOSCIENCE, INC.
Vermögen: 16 350 $ am 30.09.2026
Profil
Dr. Christopher G.
Twitty is a Chief Scientific Officer at Skye Bioscience, Inc. Dr. Twitty was previously employed as a Chief Scientific Officer by Onchilles Pharma, Inc., an Independent Director by Larkspur Health Acquisition Corp., and a Chief Scientific Officer, Head-R&D by OncoSec Medical, Inc. He received his undergraduate degree from San Diego State University and a doctorate degree from Oregon Health & Science University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SKYE BIOSCIENCE, INC. 0,23 % | 31.03.2026 | 10 155 ( 0,23 % ) | 16 350 $ | 30.09.2026 |
Aktive Positionen von Christopher Twitty
| Unternehmen | Position | Beginn |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.12.2022 |
Ehemalige bekannte Positionen von Christopher Twitty
| Unternehmen | Position | Ende |
|---|---|---|
Onchilles Pharma, Inc.
 Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2022 |
| ONCOSEC MEDICAL INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 20.10.2021 |
| LARR HEALPAR | Direktor/Vorstandsmitglied | - |
Ausbildung von Christopher Twitty
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oregon Health & Science University
 Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Onchilles Pharma, Inc.
Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Commercial Services |
Larkspur Health Acquisition Corp.
 Larkspur Health Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
